Gating and Regulation of Connexin Hemichannels
连接蛋白半通道的门控和调节
基本信息
- 批准号:9402712
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteArrhythmiaBindingBiophysicsBlood VesselsBrainBrain DiseasesC-terminalCardiacCardiac MyocytesCardiac healthCardiovascular DiseasesCardiovascular PathologyCell DeathCell membraneCellsCessation of lifeComplexConnexin 43ConnexinsCysteineCytoplasmic TailDataDevelopmentDiseaseDisease modelElectrophysiology (science)Fluorescence SpectroscopyFunctional disorderGap JunctionsGoalsHeartHeart DiseasesHereditary DiseaseHyperactive behaviorIntercalated discIonsIschemiaKnowledgeLateralLeadMass Spectrum AnalysisMediatingMembraneMetabolicMethodologyModificationMolecularMuscle CellsMuscular DystrophiesMutagenesisMyocardial InfarctionNMR SpectroscopyNitric OxideNitric Oxide DonorsNitric Oxide SynthaseNitrosationOrganPathologicPathologyPeptidesPermeabilityPharmacologic SubstancePharmacologyPlayProtein IsoformsProteinsRegulationResearchRoleSignal TransductionSiteSpectrum AnalysisSystemTestingTherapeuticTissuesVentricularWorkaqueousconnexin poredesignextracellulargenetic approachinnovationinsightinterdisciplinary approachnovelpreventsmall moleculetherapy outcometool
项目摘要
Connexin 43 (Cx43) in the heart is normally expressed at the intercalated disk where it commonly forms
junctional channels (gap junctions). Many cardiac diseases produce increased or aberrant expression of Cx43,
which results in lateralization of the protein in cardiomyocytes. Our group and others have provided evidence
that lateralized Cx43 forms unpaired hyperactive hemichannels (non-junctional channels) at the plasma
membrane. Excessive opening of these Cx43 hemichannels is associated with cell death during acute
ischemia and cardiac muscular dystrophy. Cell death is thought to result from the loss of electrochemical
gradients and small cytoplasmic metabolites through the large and modest selective aqueous pore of connexin
hemichannels. We and others have indirect evidence indicating that nitric oxide (NO) opens Cx43
hemichannels, promoting cellular dysfunction in the heart and brain. In addition, we have evidence that under
conditions that cause lateralization in cardiomyocytes, Cx43 is S-nitrosated. The molecular mechanisms that
cause Cx43 hemichannel opening by NO have not been elucidated, despite the importance this may have in
cardiac and other pathologies. We propose that a major contributor to the aberrant opening of undocked
hemichannels is Cx43 S-nitrosation. In this proposal, we will take advantage of our expertise in connexin
hemichannel biophysics to identify the mechanisms by which NO gates Cx43 hemichannels. Specific Aim 1 will
determine whether NO directly opens Cx43 hemichannels via S-nitrosation and identify residues involved.
Specific Aim 2 will identify the precise cytoplasmic domain interactions that mediate the effects of NO on Cx43
gating. Specific Aim 3 will determine whether S-nitrosated Cx43 hemichannels promote cell and tissue
damage. We plan to accomplish these specific aims using an integrative multidisciplinary approach that
combines electrophysiology, mutagenesis, fluorescence and NMR spectroscopy, mass spectrometry, and a
cardiac disease model. We expect that our work will contribute to the rational development of new
pharmacological strategies to target the specific connexin domains involved in aberrant hemichannel gating.
This will allow us to achieve specific therapeutic outcomes, for example, to decrease opening of hyperactive
hemichannels during myocardial infarction preventing arrhythmias and tissue damage.
心脏中的连接蛋白43(Cx43)通常在其通常形成的闰盘处表达
连接通道(缝隙连接)。许多心脏疾病引起Cx43表达增加或异常,
这导致心肌细胞中蛋白质的偏侧化。我们的团队和其他人提供了证据
侧化Cx43在血浆中形成不成对的过度活跃的半通道(非连接通道),
膜的这些Cx43半通道的过度开放与急性期细胞死亡相关。
局部缺血和心肌营养不良。细胞死亡被认为是由于电化学损失造成的
梯度和小的细胞质代谢物通过连接蛋白的大的和适度的选择性水孔
半通道我们和其他人有间接证据表明,一氧化氮(NO)打开Cx43
半通道,促进心脏和大脑的细胞功能障碍。此外,我们有证据表明,
在导致心肌细胞偏侧化的条件下,Cx43被S-亚硝化。的分子机制
导致Cx43半通道开放的NO尚未阐明,尽管这可能具有重要性,
心脏病和其他疾病。我们认为,一个主要的贡献者异常开放的非对接
半通道是Cx43 S-亚硝化。在这个提议中,我们将利用我们在连接蛋白方面的专长,
半通道生物物理学以鉴定NO门控Cx43半通道的机制。具体目标1将
确定NO是否通过S-亚硝化直接打开Cx43半通道并鉴定所涉及的残基。
特异性目的2将鉴定介导NO对Cx43的作用的精确胞质结构域相互作用
门控具体目标3将确定S-亚硝化的Cx43半通道是否促进细胞和组织
损害我们计划采用综合性多学科方法来实现这些具体目标,
结合了电生理学、诱变、荧光和NMR光谱学、质谱学,以及
心脏病模型我们期望,我们的工作将有助于合理发展新的
针对参与异常半通道门控的特定连接蛋白结构域的药理学策略。
这将使我们能够实现特定的治疗结果,例如,减少过度活跃的开放
在心肌梗死期间的半通道,防止心律失常和组织损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jorge Enrique Contreras其他文献
Jorge Enrique Contreras的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jorge Enrique Contreras', 18)}}的其他基金
Role of S-nitrosylated Cx43 in normal cardiac contractility
S-亚硝基化 Cx43 在正常心肌收缩力中的作用
- 批准号:
10599329 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别:
Connexin 43: a new player in Duchenne muscular dystrophy associated cardiomyopathy
Connexin 43:杜氏肌营养不良症相关心肌病的新参与者
- 批准号:
9494823 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Connexin 43: a new player in Duchenne muscular dystrophy associated cardiomyopathy
Connexin 43:杜氏肌营养不良症相关心肌病的新参与者
- 批准号:
10186788 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cx26 and Cx32 Channels by Cytosolic Interdomain Interactions
胞浆域间相互作用对 Cx26 和 Cx32 通道的调节
- 批准号:
8711872 - 财政年份:2013
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cx26 and Cx32 Channels by Cytosolic Interdomain Interactions
胞浆域间相互作用对 Cx26 和 Cx32 通道的调节
- 批准号:
8475966 - 财政年份:2013
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cx26 and Cx32 Channels by Cytosolic Interdomain Interactions
胞浆域间相互作用对 Cx26 和 Cx32 通道的调节
- 批准号:
9041629 - 财政年份:2013
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cx26 and Cx32 Channels by Cytosolic Interdomain Interactions
胞浆域间相互作用对 Cx26 和 Cx32 通道的调节
- 批准号:
8795731 - 财政年份:2013
- 资助金额:
$ 39.38万 - 项目类别:
Gating and Regulation of Connexin Hemichannels
连接蛋白半通道的门控和调节
- 批准号:
10379607 - 财政年份:2011
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:














{{item.name}}会员




